Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
The Journal of Clinical Investigation
|
May 16, 2012
CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma
Jian Hong, Kaishun Hu, Yunfei Yuan, et al.
Journal of Cancer
|
July 9, 2019
Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study
Wenwu Liu, Zhiwen Yang, Ruhai Zou, et al.
Theranostics
|
May 7, 2020
Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma
Yadi Liao, Chenwei Wang, Zhiwen Yang, et al.
Therapeutic Advances in Medical Oncology
|
October 8, 2019
Microwave ablation <i>versus</i> resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis
Wenwu Liu, Ruhai Zou, Chenwei Wang, et al.
Hepatology (Baltimore, Md.)
|
February 20, 2021
Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model
Chen Qu, Lu He, Nan Yao, et al.
European Radiology
|
April 18, 2019
Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation
Zhiwen Yang, Ruhai Zou, Yun Zheng, et al.
Clinical and Molecular Hepatology
|
January 20, 2026
COLEC12high TAMs Orchestrate Lenvatinib Resistance and Cancer Stemness in HCC via Paracrine NRG1-HER2/HER3 Signaling
Jianxing Zhang, Liang Qiao, Zongfeng Wu, et al.
Cancer Research
|
June 18, 2026
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis
Yi Zeng, Zhenkun Huang, Jiliang Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2017
CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study
Jiliang Qiu, Baogang Peng, Yunqiang Tang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 18, 2022
Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
Chenwei Wang, Yadi Liao, Wei He, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
The Journal of Clinical Investigation
|
May 16, 2012
CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma
Jian Hong, Kaishun Hu, Yunfei Yuan, et al.
Journal of Cancer
|
July 9, 2019
Resection vs Ablation for Multifocal Hepatocellular Carcinomas meeting the Barcelona-Clinic Liver Cancer A Classification: A Propensity Score Matching Study
Wenwu Liu, Zhiwen Yang, Ruhai Zou, et al.
Theranostics
|
May 7, 2020
Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma
Yadi Liao, Chenwei Wang, Zhiwen Yang, et al.
Therapeutic Advances in Medical Oncology
|
October 8, 2019
Microwave ablation <i>versus</i> resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis
Wenwu Liu, Ruhai Zou, Chenwei Wang, et al.
Hepatology (Baltimore, Md.)
|
February 20, 2021
Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model
Chen Qu, Lu He, Nan Yao, et al.
European Radiology
|
April 18, 2019
Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation
Zhiwen Yang, Ruhai Zou, Yun Zheng, et al.
Clinical and Molecular Hepatology
|
January 20, 2026
COLEC12high TAMs Orchestrate Lenvatinib Resistance and Cancer Stemness in HCC via Paracrine NRG1-HER2/HER3 Signaling
Jianxing Zhang, Liang Qiao, Zongfeng Wu, et al.
Cancer Research
|
June 18, 2026
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis
Yi Zeng, Zhenkun Huang, Jiliang Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 10, 2017
CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study
Jiliang Qiu, Baogang Peng, Yunqiang Tang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 18, 2022
Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
Chenwei Wang, Yadi Liao, Wei He, et al.
Page
of 9